Strain Echocardiography During Septic Shock : an Observational Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Shock, Septic
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Global peak systolic longitudinal strain assessed by echocardiography. Global peak systolic longitudinal strain
- Status
- Completed
- Last Updated
- 5 months ago
Overview
Brief Summary
The mortality of septic shock remains high nowadays despite a trend toward improvement.Septic cardiomyopathy has been reported in most experimental models of sepsis shock. Its relationship with mortality is unclear. A decrease in mortality have been reported in patients with decreased left ventricular ejection fraction (LVEF), but a recent meta-analysis did not support such results. In fact, it appears that high LVEF are linked to profound vasoplegia which is associated to bad outcome.
In the other hand, alterations of Strain echocardiography, a new method allowing a more sensitive evaluation of heart function, have been associated with a worse outcome in sepsis patients. Only few studies have examined echocardiographic strain during sepsis shock in human, and its natural history was only described in pigs. Moreover, the right ventricular strain was reported only by Orde et al whereas the evolution of strain during fluid infusion have never been studied. The aim of the present study is to describe the natural history of echocardiographic strain during sepsis shock and to determine its prognosis value.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Septic shock (suspected or proven infection and norepinephrine ≥ 0,25µg/kg/min)
- •Inclusion within the first 24h of septic shock
Exclusion Criteria
- •Patient \< 18 year of age
- •Pregnant women
- •History of myocardial infarction, valvular disease, atrial fibrillation
Outcomes
Primary Outcomes
Global peak systolic longitudinal strain assessed by echocardiography. Global peak systolic longitudinal strain
Time Frame: up to 90 days
Secondary Outcomes
- ICU mortality(up to 90 days)